Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla

Diseases of Aquatic Organisms

Volumn 43, Issue 2, 2000, Pages 91-101

  Collado, R ^a   Fouz, B ^a   Sanjuan, E ^a   Amaro, C ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Eel vaccines; Vaccination by injection; Vaccination by prolonged immersion; Vibrio vaccines; Vibrio vuinificus serovar E; Vibrio vulnificus biotype 2

Indexed keywords

ANGUILLA ANGUILLA; ANTIBODY PRODUCTION; BIOTYPE; DRUG DELIVERY SYSTEM; EUROPE; IMMUNE RESPONSE; SEROVAR; SURVIVAL; VACCINATION; VACCINE PRODUCTION; VIBRIO VULNIFICUS; VIBRIOSIS;

EID: 0034649281     PISSN: 01775103     EISSN: None     Source Type: Journal    
DOI: 10.3354/dao043091     Document Type: Article

References (59)

1. The immune response of turbot (Scophthalmus maximus L.) to formolized and heat inactivated cells, and subcellular components of a fish pathogenic Cytophaga-like bacterium (CLB)
2. Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans
3. Electrophoretic analysis of heterogeneous lipopolysaccharides from various strains of Vibrio vulnificus biotypes 1 and 2 by silver staining and immunoblotting
4. Comparative study of phenotypic and virulence properties in Vibrio vulnificus biotype 1 and 2 obtained from a European eel farm experiencing mortalities
5. Role of iron, capsule, and toxins in the pathogenicity of Vibrio vulnificus biotype 2 for mice
6. Evidence that water transmits Vibrio vulnificus biotype 2 infections to eels
7. The lipopolysaccharide O side chain of Vibrio vulnificus serogroup E is a virulence determinant for eels
8. Potency testing of fish vaccines
9. Vaccine for the control of vibriosis in eels
10. Vibrionaceae representatives
11. Natural antibacterial compounds on the surface of rainbow trout, Salmo gairdneri Richardson
12. Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity
13. First record of Vibrio vulnificus biotype 2 from diseased European eel, Anguilla anguilla L
14. Comparison of the outer membrane profile of Vibrio vulnificus biotypes 1 and 2
15. Presence of a capsule in Vibno vulnificus biotype 2 and its relationship to virulence for eels
16. Phenotypic characterization of Vibrio vulnificus biotype 2, a lipopolysaccharide-based homogeneous serogroup within Vibrio vulnificus
17. Pheno, typic and genotypic characterization of Vibrio vulnificus: Proposal for the substitution of the subspecilic taxon for serovar
18. An enzyme-linked immunosorbent assay for detection of Vibrio vulnificus biotype 2: Development and field studies
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
20. The seasonal antibody response in juvenile summer flounder (Paralychthys dentatus) to the hemoflagellate Tripanoplasma bullocki
21. Detection of Vibrio anguillarum antigen by the dot blot assay
22. Acquired immunity to amyloodiniosis is associated with antibody response
23. Indole-positive Vibrio vulnificus isolated from disease outbreaks on a Danish eel farm
24. Effects of oral vaccination against vibriosis in turbot, Scophthalmus maximus (L.) and sea bass, Dicentrachus labrax (L.)
25. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent, sodium lauryl sarkosynate
26. Vaccination of yellowtail against psedotuberculosis
27. Immunity to extracellular bacteria
28. Bivalent vaccines for sea bass (Dicentrachus labrax) against vibriosis and pasteurellosis
29. Responses of Japanese eels to oral challenge with Edwarsiella tarda after vaccination with formalin-killed cells or lipopolysaccharide of the bacterium
30. Comparison of the pour, spread and drop plate methods for enumeration of Rhizobium spp. in inoculants made from presterilized peat
31. Strategies of fish vaccination
32. Defense mechanism of Ayu skin mucus
33. Immunization of cultured juvenile rockfish Sebastes schlegeli against Microcotyle sebastis (Monogea)
34. A successful vaccination trial with a trivalent vaccine
35. Survey of hemolysin production among species of Peudomonads
36. Immune response of rainbow trout (Oncorhynchus mykiss, Walbaum) to Aeromonas hydrophila
37. Vaccination trials on gilthead seabream (Sparus aurata) against Pasteurella piscicida
38. Protection of gilthead seabream against Pasteurella piscicida at the larval stages
39. Pathogenic Vibrio isolated from culture eels. I. Characteristics and taxonomic status
40. Pathogenic Vibrio isolated from culture eels. I. Physiological characteristics and pathogenicity
41. Route of vaccine administration: Effects on the specific humoral response in rainbow trout Oncorhynchus mykiss
42. Vaccination of juvenile turbot, Scophthalmus maximus L., against vibriosis
43. Bacterial agglutination
44. Long-lasting protection against turbot streptococcosis obtained with a toxoid-enriched bacterin
45. Immunization of carp (Cyprinus carpio) with Vibrio anguillarum bacterin: Indications for a common mucosal immune system
46. Protective immunity induced by a commercial Vibrio vaccine in hybrid striped bass
47. Immune response of channel catfish to lipopolysaccharide and whole cell Edwarsiella ictaluri vaccines
48. Vaccine preparations used for immunization of eel Anguilla japonica against Edwarsiella tarda infection
49. Protection of turbot, Scophthalmus maximus (L.), and rainbow trout, Oncorhynchus mykiss (Richardson), against vibriosis using two different vaccines
50. Vaccination against vibriosis
51. The immuno-responses of eel (Anguilla japonica) against Edwarsiella anguillimortifera as studied by the immersion method
52. Vaccination conditions for the eel (Anguilla anguilla) with Edwarsiella anguillimortifera bacterin
53. Vibrio vulnificus biogroup 2: New biogroup pathogenic for eels
54. Efficacy of intraperitoneal and immersion vaccination against Enterococcus sp. infection in turbot
55. Protective immunity in juvenile coho salmon Oncorhynchus kisutch following immunization with Vibrio Ordalii lipopolysaccharide or from exposure to live V. ordalii cells
56. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedures